| Aryl hydrocarbon receptor control of a disease tolerance defence pathway A Bessede, M Gargaro, MT Pallotta, D Matino, G Servillo, C Brunacci, ... Nature 511 (7508), 184-190, 2014 | 654 | 2014 |
| WDFY4 is required for cross-presentation in response to viral and tumor antigens DJ Theisen, JT Davidson IV, CG Briseño, M Gargaro, EJ Lauron, Q Wang, ... Science 362 (6415), 694-699, 2018 | 253 | 2018 |
| An Nfil3–Zeb2–Id2 pathway imposes Irf8 enhancer switching during cDC1 development P Bagadia, X Huang, TT Liu, V Durai, GE Grajales-Reyes, M Nitschké, ... Nature immunology 20 (9), 1174-1185, 2019 | 96 | 2019 |
| Tryptophan feeding of the IDO1-AhR axis in host–microbial symbiosis T Zelante, RG Iannitti, F Fallarino, M Gargaro, A De Luca, S Moretti, ... Frontiers in immunology 5, 125773, 2014 | 78 | 2014 |
| Anti-ferroptotic mechanism of IL4i1-mediated amino acid metabolism L Zeitler, A Fiore, C Meyer, M Russier, G Zanella, S Suppmann, M Gagaro, ... Elife 10, e64806, 2021 | 69 | 2021 |
| Positive allosteric modulation of indoleamine 2, 3-dioxygenase 1 restrains neuroinflammation G Mondanelli, A Coletti, FA Greco, MT Pallotta, C Orabona, A Iacono, ... Proceedings of the National Academy of Sciences 117 (7), 3848-3857, 2020 | 64 | 2020 |
| Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice F Fazio, C Zappulla, S Notartomaso, C Busceti, A Bessede, P Scarselli, ... Neuropharmacology 81, 237-243, 2014 | 60 | 2014 |
| Distinct roles of immunoreceptor tyrosine‐based motifs in immunosuppressive indoleamine 2, 3‐dioxygenase 1 E Albini, V Rosini, M Gargaro, G Mondanelli, ML Belladonna, MT Pallotta, ... Journal of cellular and molecular medicine 21 (1), 165-176, 2017 | 59 | 2017 |
| Forced IDO 1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes MT Pallotta, C Orabona, R Bianchi, C Vacca, F Fallarino, ML Belladonna, ... Journal of cellular and molecular medicine 18 (10), 2082-2091, 2014 | 59 | 2014 |
| IL‐35, a hallmark of immune‐regulation in cancer progression, chronic infections and inflammatory diseases M Teymouri, M Pirro, F Fallarino, M Gargaro, A Sahebkar International journal of cancer 143 (9), 2105-2115, 2018 | 54 | 2018 |
| Altered compensatory cytokine signaling underlies the discrepancy between Flt3–/–and Flt3l–/–mice V Durai, P Bagadia, CG Briseño, DJ Theisen, A Iwata, JT Davidson, ... Journal of Experimental Medicine 215 (5), 1417-1435, 2018 | 54 | 2018 |
| IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII D Matino, M Gargaro, E Santagostino, MND Di Minno, G Castaman, ... The Journal of Clinical Investigation 125 (10), 3766-3781, 2015 | 51 | 2015 |
| Engagement of nuclear coactivator 7 by 3-hydroxyanthranilic acid enhances activation of aryl hydrocarbon receptor in immunoregulatory dendritic cells M Gargaro, C Vacca, S Massari, G Scalisi, G Manni, G Mondanelli, ... Frontiers in Immunology 10, 1973, 2019 | 49 | 2019 |
| Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite G Renga, E Nunzi, M Pariano, M Puccetti, MM Bellet, G Pieraccini, ... Journal for immunotherapy of cancer 10 (3), 2022 | 48 | 2022 |
| Ligand Binding and Functional Selectivity of l-Tryptophan Metabolites at the Mouse Aryl Hydrocarbon Receptor (mAhR) R Nuti, M Gargaro, D Matino, D Dolciami, U Grohmann, P Puccetti, ... Journal of chemical information and modeling 54 (12), 3373-3383, 2014 | 47 | 2014 |
| Indoleamine 2, 3-dioxygenase 1 activation in mature cDC1 promotes tolerogenic education of inflammatory cDC2 via metabolic communication M Gargaro, G Scalisi, G Manni, CG Briseño, P Bagadia, V Durai, ... Immunity 55 (6), 1032-1050. e14, 2022 | 46 | 2022 |
| Onion (Allium cepa L.) Skin: A Rich Resource of Biomolecules for the Sustainable Production of Colored Biofunctional Textiles L Pucciarini, F Ianni, V Petesse, F Pellati, V Brighenti, C Volpi, M Gargaro, ... Molecules 24 (3), 634, 2019 | 46 | 2019 |
| Stem cells from human amniotic fluid exert immunoregulatory function via secreted indoleamine 2,3‐dioxygenase1 R Romani, I Pirisinu, M Calvitti, MT Pallotta, M Gargaro, G Bistoni, ... Journal of cellular and molecular medicine 19 (7), 1593-1605, 2015 | 46 | 2015 |
| Targeting metabotropic glutamate receptors for the treatment of neuroinflammation F Fazio, M Ulivieri, C Volpi, M Gargaro, F Fallarino Current Opinion in Pharmacology 38, 16-23, 2018 | 43 | 2018 |
| LPS-conditioned dendritic cells confer endotoxin tolerance contingent on tryptophan catabolism F Fallarino, MT Pallotta, D Matino, M Gargaro, C Orabona, C Vacca, ... Immunobiology 220 (2), 315-321, 2015 | 42 | 2015 |
Francesca FallarinoFull Professor of PharmacologyVerified email at unipg.it
